Confluent hepatic fibrosis in alcohol liver cirrhosis with elevated pivkaii value - usefulness of immunostaining for EZH2 and p16(INK4a) in differentiating it from cholangiolocellular carcinoma - Confluent hepatic fibrosis

Kim Soo Ki; Kim Soo Ryang; Imoto Susumu; Kim Chi Wan; Matsuoka Toshiyuki; Sasaki Motoko; Nakashima Osamu; Kumabe Tsutomu; Hayashi Yoshitake

首页> 外文期刊>Pathology International >Confluent hepatic fibrosis in alcohol liver cirrhosis with elevated pivkaii value - usefulness of immunostaining for EZH2 and p16(INK4a) in differentiating it from cholangiolocellular carcinoma - Confluent hepatic fibrosis

【24h】

Confluent hepatic fibrosis in alcohol liver cirrhosis with elevated pivkaii value - usefulness of immunostaining for EZH2 and p16(INK4a) in differentiating it from cholangiolocellular carcinoma - Confluent hepatic fibrosis

机译：pivkaii值升高的酒精性肝硬化合并肝纤维化-EZH2和p16（INK4a）免疫染色在区分胆管细胞癌中的作用-合并肝纤维化

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Pathology International》 |2016年第9期|共3页
作者
Kim Soo Ki; Kim Soo Ryang; Imoto Susumu; Kim Chi Wan; Matsuoka Toshiyuki; Sasaki Motoko; Nakashima Osamu; Kumabe Tsutomu; Hayashi Yoshitake;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类病理学;
关键词
入库时间 2022-08-18 17:35:12

相似文献

外文文献
中文文献
专利

1. Confluent hepatic fibrosis in alcohol liver cirrhosis with elevated pivkaii value - usefulness of immunostaining for EZH2 and p16(INK4a) in differentiating it from cholangiolocellular carcinoma - Confluent hepatic fibrosis [J] . Kim Soo Ki, Kim Soo Ryang, Imoto Susumu, Pathology International . 2016,第9期

机译：pivkaii值升高的酒精性肝硬化合并肝纤维化-EZH2和p16（INK4a）免疫染色在区分胆管细胞癌中的作用-合并肝纤维化
2. Confluent hepatic fibrosis as the presenting imaging sign in nonadvanced alcoholic cirrhosis. [J] . Kelekis NL, Makri E, Vassiou A, Clinical imaging . 2004,第2期

机译：融合性肝纤维化是非晚期酒精性肝硬化的影像学表现。
3. Confluent hepatic fibrosis in cirrhosis: ferumoxides-enhanced MR imaging findings. [J] . Matsuo M, Kanematsu M, Kondo H, Abdominal imaging. . 2001,第2期

机译：肝硬化中的融合性肝纤维化：阿魏酸盐增强的MR成像发现。
4. Investigating the biochemical progression of liver disease through fibrosis, cirrhosis, dysplasia, and hepatocellular carcinoma using Fourier Transform Infrared Spectroscopic imaging [C] . Hari Sreedhar, Mamta Pant, Nemencio R Ronquillo, Biomedical vibrational spectroscopy VI: Advances in research and industry . 2014

机译：使用傅立叶变换红外光谱成像技术研究通过纤维化，肝硬化，异型增生和肝细胞癌引起的肝脏疾病的生化进程
5. Emerging Roles of Platelet-Derived Growth Factor Receptor Alpha in Chronic Liver Injury: Potential Therapeutic Target in Hepatic Fibrosis [D] . Kikuchi, Alexander Thomas. 2017

机译：血小板源性生长因子受体α在慢性肝损伤中的新兴作用：肝纤维化的潜在治疗靶点。
6. In vivo hepatic differentiation potential of human umbilical cord-derived mesenchymal stem cells: Therapeutic effect on liver fibrosis/cirrhosis [O] . Guo-Zun Zhang, Hui-Cong Sun, Li-Bo Zheng, 2017

机译：人脐带间充质干细胞的体内肝分化潜能：对肝纤维化/肝硬化的治疗作用
7. Confluent hepatic fibrosis in liver cirrhosis: Possible relation with middle hepatic venous drainage [O] . Ozaki, Kumi, Matsui, Osamu, Gabata, Toshifumi, 2013

机译：肝硬化合并肝纤维化：可能与肝中静脉引流有关

Confluent hepatic fibrosis in alcohol liver cirrhosis with elevated pivkaii value - usefulness of immunostaining for EZH2 and p16(INK4a) in differentiating it from cholangiolocellular carcinoma - Confluent hepatic fibrosis

著录项

相似文献

相关主题

期刊订阅